Geneos Wealth Management’s Unilever UL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-12,296
| Closed | -$820K | – | 2561 |
|
|
2025
Q3 | $820K | Sell |
12,296
-3,399
| -22% | -$235K | 0.02% | 535 |
|
|
2025
Q2 | $1.08M | Buy |
15,695
+2,266
| +17% | +$159K | 0.03% | 516 |
|
|
2025
Q1 | $900K | Buy |
13,429
+2,661
| +25% | +$172K | 0.03% | 481 |
|
|
2024
Q4 | $687K | Buy |
10,768
+1,395
| +15% | +$94.2K | 0.02% | 501 |
|
|
2024
Q3 | $685K | Buy |
9,373
+2,177
| +30% | +$150K | 0.03% | 484 |
|
|
2024
Q2 | $445K | Buy |
7,196
+1,422
| +25% | +$84K | 0.02% | 520 |
|
|
2024
Q1 | $326K | Buy |
5,774
+1,074
| +23% | +$59.5K | 0.01% | 583 |
|
|
2023
Q4 | $256K | Sell |
4,700
-858
| -15% | -$46.3K | 0.01% | 612 |
|
|
2023
Q3 | $309K | Buy |
5,558
+40
| +0.7% | +$2.31K | 0.02% | 574 |
|
|
2023
Q2 | $324K | Buy |
5,518
+1,101
| +25% | +$65.4K | 0.02% | 567 |
|
|
2023
Q1 | $258K | Sell |
4,417
-3,170
| -42% | -$180K | 0.02% | 587 |
|
|
2022
Q4 | $430K | Buy |
7,587
+1,360
| +22% | +$72.8K | 0.03% | 451 |
|
|
2022
Q3 | $307K | Sell |
6,227
-4,248
| -41% | -$222K | 0.02% | 496 |
|
|
2022
Q2 | $545K | Sell |
10,475
-88
| -0.8% | -$4.48K | 0.03% | 474 |
|
|
2022
Q1 | $541K | Buy |
10,563
+549
| +5% | +$30.6K | 0.02% | 513 |
|
|
2021
Q4 | $606K | Buy |
10,014
+122
| +1% | +$7.25K | 0.02% | 516 |
|
|
2021
Q3 | $603K | Buy |
9,892
+193
| +2% | +$12.3K | 0.02% | 524 |
|
|
2021
Q2 | $643K | Sell |
9,699
-367
| -4% | -$24.4K | 0.03% | 495 |
|
|
2021
Q1 | $664K | Buy |
10,066
+766
| +8% | +$48.8K | 0.02% | 554 |
|
|
2020
Q4 | $542K | Buy |
9,300
+4,387
| +89% | +$298K | 0.02% | 518 |
|
|
2020
Q3 | $336K | Sell |
4,913
-4
| -0.1% | -$267 | 0.02% | 528 |
|
|
2020
Q2 | $310K | Buy |
4,917
+26
| +0.5% | +$1.55K | 0.02% | 538 |
|
|
2020
Q1 | $270K | Buy |
4,891
+335
| +7% | +$21K | 0.02% | 524 |
|
|
2019
Q4 | $295K | Buy |
4,556
+255
| +6% | +$16.9K | 0.02% | 561 |
|
|
2019
Q3 | $292K | Sell |
4,301
-510
| -11% | -$35.3K | 0.02% | 534 |
|
|
2019
Q2 | $340K | Sell |
4,811
-46
| -0.9% | -$3.12K | 0.02% | 514 |
|
|
2019
Q1 | $315K | Buy |
4,857
+569
| +13% | +$34.7K | 0.02% | 515 |
|
|
2018
Q4 | $250K | Buy |
4,288
+85
| +2% | +$5.12K | 0.02% | 533 |
|
|
2018
Q3 | $259K | Sell |
4,203
-403
| -9% | -$25.4K | 0.02% | 556 |
|
|
2018
Q2 | $286K | Sell |
4,606
-58
| -1% | -$3.6K | 0.02% | 460 |
|
|
2018
Q1 | $291K | Sell |
4,664
-940
| -17% | -$57.2K | 0.03% | 432 |
|
|
2017
Q4 | $348K | Buy |
5,604
+355
| +7% | +$22.5K | 0.03% | 397 |
|
|
2017
Q3 | $342K | Buy |
5,249
+1,348
| +35% | +$86.6K | 0.03% | 377 |
|
|
2017
Q2 | $237K | Buy |
3,901
+516
| +15% | +$30.8K | 0.02% | 452 |
|
|
2017
Q1 | $187K | Sell |
3,385
-212
| -6% | -$10.7K | 0.02% | 501 |
|
|
2016
Q4 | $164K | Sell |
3,597
-267
| -7% | -$12.4K | 0.02% | 505 |
|
|
2016
Q3 | $206K | Buy |
3,864
+79
| +2% | +$4.17K | 0.03% | 438 |
|
|
2016
Q2 | $204K | Buy |
3,785
+831
| +28% | +$42.7K | 0.03% | 436 |
|
|
2016
Q1 | $149K | Buy |
+2,954
| New | +$144K | 0.02% | 495 |
|
Other funds holding UL
Geneos Wealth Management's UL Position: Q4 2025 in Review
Geneos Wealth Management sold out of Unilever (UL) in Q4 2025, closing a stake of 12,296 shares — an estimated $820K sold.
Geneos Wealth Management first reported a position in UL in Q1 2016 and held it in 39 quarters. The position peaked at $1.08M in Q2 2025. 1,154 funds tracked by Wall St. Rank hold UL as of Q4 2025.
- Geneos Wealth Management reported no remaining Unilever position as of Q4 2025 after selling out during the quarter.
- Geneos Wealth Management sold 12,296 Unilever shares in Q4 2025, an estimated $820K.
- Geneos Wealth Management first reported a position in Unilever in Q1 2016 and held it in 39 quarters.
- Geneos Wealth Management's Unilever position peaked at $1.08M in Q2 2025.
- 1,154 funds tracked by Wall St. Rank held Unilever as of Q4 2025.
Based on Geneos Wealth Management's 13F filing for Q4 2025, filed 28 Jan 2026.